The following is reprinted from the January 30 issue of the UI Holden Comprehensive Cancer Center’s Holden Highlights newsletter. See other features from this series. Dr. Michael Wendt, associate professor in Hematology, Oncology and Blood and Marrow Transplantation, has been appointed Co-Leader of the Experimental Therapeutics (ET) Program at the Holden Comprehensive Cancer Center (HCCC), […]